The Enterprise Value as of December 2024 (TTM) for ImmuCell Corporation (ICCC) is 52.81M

According to ImmuCell Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 52.81M. This represents a change of 4.80% compared to the average of 50.39M of the last 4 quarters.

ImmuCell Corporation (ICCC) Historical Enterprise Value (quarterly & annually)

How has ICCC Enterprise Value performed in the past?

The mean historical Enterprise Value of ImmuCell Corporation over the last ten years is 40.71M. The current 52.81M Enterprise Value has changed 12.87% with respect to the historical average. Over the past ten years (40 quarters), ICCC's Enterprise Value was at its highest in in the March 2022 quarter at 74.93M. The Enterprise Value was at its lowest in in the December 2014 quarter at 14.76M.

ImmuCell Corporation (ICCC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ImmuCell Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ImmuCell Corporation (ICCC) Average Enterprise Value

How has ICCC Enterprise Value performed in the past?

The current Enterprise Value of ImmuCell Corporation (ICCC) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ImmuCell Corporation (ICCC) Enterprise Value vs. Peers

How is ICCC’s Enterprise Value compared to its peers?

ImmuCell Corporation’s Enterprise Value is less than Transgene SA (76.48M), greater than Alpha Cognition Inc. (34.21M), less than Fennec Pharmaceuticals Inc. (161.56M), greater than Lipella Pharmaceuticals Inc. (2.54M), less than Eliem Therapeutics, Inc. (0), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Anebulo Pharmaceuticals, Inc. (40.61M), greater than HCW Biologics Inc. (26.86M), less than MediciNova, Inc. (59.45M), greater than AgeX Therapeutics, Inc. (19.70M), less than Lineage Cell Therapeutics, Inc. (93.41M), greater than Cadrenal Therapeutics, Inc. Common Stock (20.14M), less than Oxford Nanopore Technologies plc (1.18B), less than Rezolute, Inc. (247.14M), less than XOMA Corporation (296.56M), greater than Protagenic Therapeutics, Inc. (2.29M), greater than Tempest Therapeutics, Inc. (33.01M),

Build a custom stock screener for ImmuCell Corporation (ICCC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuCell Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuCell Corporation (ICCC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuCell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.